In contrast, CD4+ T cells were increased and clustered at sites of fibrosis in the livers of the NAFLD patients (who were in the late stage of disease with evidence of NASH, cirrhosis and HCC) we studied. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.